
Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Global Forecast 2024-2030
Description
Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Global Forecast 2024-2030
The Tissue Engineering Market size was estimated at USD 43.13 billion in 2023 and expected to reach USD 51.21 billion in 2024, at a CAGR 18.82% to reach USD 144.28 billion by 2030.
Global Tissue Engineering MarketTissue engineering is a life science field that combines the principles of biology, material science, and engineering to develop functional replacements for impaired or diseased tissues and organs. It aims to restore, maintain, or improve tissue function by creating biological reserves or enhancing natural regenerative capabilities. Tissue engineering has many applications, from repairing skin, cartilage, and bone to constructing complex organs such as the heart or liver. The process usually involves using scaffolds, biodegradable structures made from synthetic or natural materials that provide mechanical support and an appropriate microenvironment for cell attachment, growth, and differentiation. Cells can be derived from the patient or donors, then seeded onto these scaffolds in combination with relevant biomolecules, such as growth factors and adhesion molecules. Tissue engineering offers several advantages compared to traditional transplantation methods. As tissue engineering uses the patient's cells or compatible donor cells, there is minimal risk of immune rejection and disease transmission. The tissue engineering market is propelled by an increasing need for efficient regenerative therapies to address irreversible tissue damage and lifestyle-related diseases and the expanding use of biogenic nanoparticles in advanced tissue engineering techniques. However, complications in developing suitable biomaterials and procedures and stringent regulations may hinder market growth. Despite these challenges, opportunities exist due to ongoing technological advancements in 3D tissue engineering and significant government support for research projects. Thus, tissue engineering is a rapidly evolving field with significant potential to revolutionize healthcare by providing novel tissue repair and regeneration treatments.
Regional Insights
The tissue engineering market is experiencing significant growth and evolution across the globe attributed to advancements in technology, increased research and development activities, rising demand for organ transplantation, and the growing prevalence of chronic diseases. In the Americas, the tissue engineering market is rapidly evolving due to increasing investments in research activities, the presence of key market players, the growing geriatric population susceptible to chronic conditions, and the implementation of favorable government policies. Federal government support in terms of policy and funding also expands the role of tissue engineering in the biomedical research field. In the EMEA region, Europe dominates the tissue engineering market due to its well-established healthcare system, the high adoption rate of advanced technologies, and significant funding from public and private sectors supporting innovative research. Additionally, collaborations between local institutions and global organizations promote further advancements in this field. Meanwhile, the APAC region has emerged as a rapidly growing market for tissue engineering owing to increasing awareness about regenerative medicine therapies among patients and healthcare providers, coupled with an expanding aging population, contributing significantly to this expansion. India's Department of Biotechnology promotes stem cell-based products for clinical applications, while Japan has embraced regulatory changes promoting regenerative medicine development through strategies such as conditional approval systems.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Tissue Engineering Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tissue Engineering Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Biomaterials
Cell Sources
Growth Factors & Bioactive Molecules
Scaffold Materials
Composite Scaffold Materials
Nano-Scaffold Materials
Natural Biological Scaffold Materials
Synthetic Biodegradable Polymer Scaffold Materials
Equipment
Bioreactors
Cell Culture Chambers
Image & Flow Cytometers
Services
Application
Cardiovascular Applications
Dental & Craniofacial Applications
Drug Testing & Development
Orthopedic Applications
Regenerative Medicine
Wound Healing
End-User
Academic & Government Research Institutes
Biotechnology & Pharmaceutical Companies
Contract Research Organizations
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Tissue Engineering Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tissue Engineering Market?
3. What are the technology trends and regulatory frameworks in the Tissue Engineering Market?
4. What is the market share of the leading vendors in the Tissue Engineering Market?
5. Which modes and strategic moves are suitable for entering the Tissue Engineering Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Tissue Engineering Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
- 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
- 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
- 5.1.2. Restraints
- 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in the field of 3D tissue engineering
- 5.1.3.2. Surging government support for tissue engineering research projects
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations associated with tissue engineering
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Tissue Engineering Market, by Product
- 6.1. Introduction
- 6.2. Biomaterials
- 6.3.1. Cell Sources
- 6.3.2. Growth Factors & Bioactive Molecules
- 6.3.3. Scaffold Materials
- 6.3.4.1. Composite Scaffold Materials
- 6.3.4.2. Nano-Scaffold Materials
- 6.3.4.3. Natural Biological Scaffold Materials
- 6.3.4.4. Synthetic Biodegradable Polymer Scaffold Materials
- 6.3. Equipment
- 6.4.1. Bioreactors
- 6.4.2. Cell Culture Chambers
- 6.4.3. Image & Flow Cytometers
- 6.4. Services
- 7. Tissue Engineering Market, by Application
- 7.1. Introduction
- 7.2. Cardiovascular Applications
- 7.3. Dental & Craniofacial Applications
- 7.4. Drug Testing & Development
- 7.5. Orthopedic Applications
- 7.6. Regenerative Medicine
- 7.7. Wound Healing
- 8. Tissue Engineering Market, by End-User
- 8.1. Introduction
- 8.2. Academic & Government Research Institutes
- 8.3. Biotechnology & Pharmaceutical Companies
- 8.4. Contract Research Organizations
- 9. Americas Tissue Engineering Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Tissue Engineering Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Tissue Engineering Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Agreement, Collaboration, & Partnership
- 12.3.1.1. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
- 12.3.2. New Product Launch & Enhancement
- 12.3.2.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
- 12.3.2.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AbbVie Inc.
- 13.1.2. Aspect Biosystems Ltd.
- 13.1.3. B. Braun SE
- 13.1.4. Baxter International Inc.
- 13.1.5. Bayer AG
- 13.1.6. Becton, Dickinson and Company
- 13.1.7. Cook Group Incorporated
- 13.1.8. Corning Incorporated
- 13.1.9. CTIBiotech
- 13.1.10. Frequency Therapeutics
- 13.1.11. Gel4Med
- 13.1.12. General Electric Company
- 13.1.13. Humacyte, Inc.
- 13.1.14. Integra LifeSciences Corporation
- 13.1.15. Johnson & Johnson Services, Inc.
- 13.1.16. Medtronic PLC
- 13.1.17. Merck KGaA
- 13.1.18. Miromatrix Medical, Inc.
- 13.1.19. Modern Meadow
- 13.1.20. Novartis AG
- 13.1.21. Organogenesis Inc.
- 13.1.22. Organovo Holdings, Inc.
- 13.1.23. Pfizer Inc.
- 13.1.24. Prellis Biologics
- 13.1.25. ReproCell Inc.
- 13.1.26. Smith & Nephew PLC
- 13.1.27. Stryker Corporation
- 13.1.28. Tissue Regeneration Systems Inc.
- 13.1.29. Vericel Corporation
- 13.1.30. Zimmer Biomet Holdings, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TISSUE ENGINEERING MARKET RESEARCH PROCESS
- FIGURE 2. TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
- FIGURE 3. TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TISSUE ENGINEERING MARKET DYNAMICS
- FIGURE 7. TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.